These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1770782)
1. Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders. Wanders RJ; Ijlst L; van Elk E; de Klerk JB; Przyrembel H J Inherit Metab Dis; 1991; 14(3):317-20. PubMed ID: 1770782 [No Abstract] [Full Text] [Related]
2. Fatty acid beta-oxidation in leukocytes from control subjects and medium-chain acyl-CoA dehydrogenase deficient patients. Wanders RJ; Ijlst L Biochim Biophys Acta; 1992 Jan; 1138(1):80-4. PubMed ID: 1737072 [TBL] [Abstract][Full Text] [Related]
3. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders. Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014 [TBL] [Abstract][Full Text] [Related]
4. Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. Brivet M; Slama A; Saudubray JM; Legrand A; Lemonnier A Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():154-9. PubMed ID: 7785942 [TBL] [Abstract][Full Text] [Related]
5. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects. Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847 [No Abstract] [Full Text] [Related]
6. The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. Olpin SE; Manning NJ; Pollitt RJ; Bonham JR; Downing M; Clark S Adv Exp Med Biol; 1999; 466():321-5. PubMed ID: 10709659 [No Abstract] [Full Text] [Related]
7. Effects of glucose starvation on the oxidation of fatty acids by maize root tip mitochondria and peroxisomes: evidence for mitochondrial fatty acid beta-oxidation and acyl-CoA dehydrogenase activity in a higher plant. Dieuaide M; Couée I; Pradet A; Raymond P Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):199-207. PubMed ID: 8250843 [TBL] [Abstract][Full Text] [Related]
8. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. Manning NJ; Olpin SE; Pollitt RJ; Webley J J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149 [TBL] [Abstract][Full Text] [Related]
10. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects. Divry P; Vianey-Saban C; Mathieu M J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388 [No Abstract] [Full Text] [Related]
11. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916 [TBL] [Abstract][Full Text] [Related]
12. Clinical diagnosis of long-chain acyl-coenzyme A-dehydrogenase deficiency: use of stress and fat-loading tests. Parini R; Garavaglia B; Saudubray JM; Bardelli P; Melotti D; Zecca G; Di Donato S J Pediatr; 1991 Jul; 119(1 Pt 1):77-80. PubMed ID: 2066862 [No Abstract] [Full Text] [Related]
13. C6-C10-dicarboxylic aciduria: biochemical considerations in relation to diagnosis of beta-oxidation defects. Gregersen N; Kølvraa S; Mortensen PB; Rasmussen K Scand J Clin Lab Invest Suppl; 1982; 161():15-27. PubMed ID: 6959231 [TBL] [Abstract][Full Text] [Related]
14. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation. Seargeant LE; Balachandra K; Mallory C; Dilling LA; Greenberg CR J Inherit Metab Dis; 1999 Aug; 22(6):740-6. PubMed ID: 10472534 [TBL] [Abstract][Full Text] [Related]
15. Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis. Downing M; Allen JC; Bonham JR; Edwards RG; Manning NJ; Olpin SE; Pollitt RJ J Inherit Metab Dis; 1999 May; 22(3):289-92. PubMed ID: 10384389 [No Abstract] [Full Text] [Related]
16. The diagnosis and biochemical investigation of a patient with a short chain fatty acid oxidation defect. Bennett MJ; Gray RG; Isherwood DM; Murphy N; Pollitt RJ J Inherit Metab Dis; 1985; 8 Suppl 2():135-6. PubMed ID: 3930866 [No Abstract] [Full Text] [Related]
17. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency. Jones PM; Butt Y; Bennett MJ Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125 [TBL] [Abstract][Full Text] [Related]
18. An accurate and sensitive assay of [14C]octanoate oxidation and its application on tissue homogenates and fibroblasts. Veerkamp JH; van Moerkerk HT; Bakkeren JA Biochim Biophys Acta; 1986 Mar; 876(1):133-7. PubMed ID: 3081042 [TBL] [Abstract][Full Text] [Related]
19. Effect of norepinephrine on ketogenesis, fatty acid oxidation, and esterification in isolated rat hepatocytes. Oberhaensli RD; Schwendimann R; Keller U Diabetes; 1985 Aug; 34(8):774-9. PubMed ID: 2862086 [TBL] [Abstract][Full Text] [Related]
20. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data. Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H J Inherit Metab Dis; 2014 Jan; 37(1):137-9. PubMed ID: 23807318 [No Abstract] [Full Text] [Related] [Next] [New Search]